VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, has entered...
ReNAgade Therapeutics is a company aiming to unlock the unlimited potential of RNA medicines. the company announced the appointment of Laurie Stelzer as chief...
